Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.69 USD
−46.66 M USD
58.45 M USD
30.76 M
About TELA Bio, Inc.
Sector
Industry
CEO
Antony Koblish
Website
Headquarters
Malvern
Founded
2012
FIGI
BBG004CH7Z50
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TELA is 2.87 USD — it has decreased by −0.34% in the past 24 hours. Watch TELA Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TELA Bio, Inc. stocks are traded under the ticker TELA.
TELA stock has risen by 3.93% compared to the previous week, the month change is a −4.59% fall, over the last year TELA Bio, Inc. has showed a −54.23% decrease.
We've gathered analysts' opinions on TELA Bio, Inc. future price: according to them, TELA price has a max estimate of 12.00 USD and a min estimate of 5.00 USD. Watch TELA chart and read a more detailed TELA Bio, Inc. stock forecast: see what analysts think of TELA Bio, Inc. and suggest that you do with its stocks.
TELA reached its all-time high on Jun 19, 2020 with the price of 23.55 USD, and its all-time low was 2.30 USD and was reached on Oct 10, 2024. View more price dynamics on TELA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TELA stock is 4.58% volatile and has beta coefficient of 0.42. Track TELA Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is TELA Bio, Inc. there?
Today TELA Bio, Inc. has the market capitalization of 114.62 M, it has increased by 0.35% over the last week.
Yes, you can track TELA Bio, Inc. financials in yearly and quarterly reports right on TradingView.
TELA Bio, Inc. is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
TELA earnings for the last quarter are −0.42 USD per share, whereas the estimation was −0.40 USD resulting in a −3.78% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about TELA Bio, Inc. earnings.
TELA Bio, Inc. revenue for the last quarter amounts to 18.96 M USD, despite the estimated figure of 18.85 M USD. In the next quarter, revenue is expected to reach 23.19 M USD.
TELA net income for the last quarter is −10.37 M USD, while the quarter before that showed −12.60 M USD of net income which accounts for 17.68% change. Track more TELA Bio, Inc. financial stats to get the full picture.
No, TELA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 227.00 employees. See our rating of the largest employees — is TELA Bio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TELA Bio, Inc. EBITDA is −44.71 M USD, and current EBITDA margin is −74.02%. See more stats in TELA Bio, Inc. financial statements.
Like other stocks, TELA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TELA Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TELA Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TELA Bio, Inc. stock shows the sell signal. See more of TELA Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.